FDA.reportPublic FDA data

mepolizumab 100 MG Injection [Nucala]

RxCUI
1720606
RxNorm name
mepolizumab 100 MG Injection [Nucala]
Display name
mepolizumab 100 MG Injection [Nucala]
Full name
mepolizumab 100 MG Injection [Nucala]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:30

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125526Nucalamepolizumab351(a)Rx2026-06-01
761122Nucalamepolizumab351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
fefb887c-e4ac-431e-8893-e9d1a5a63feamepolizumab 100 MG Injection [Nucala]SBD24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806
fefb887c-e4ac-431e-8893-e9d1a5a63feaNucala 100 MG InjectionPSN24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806
fefb887c-e4ac-431e-8893-e9d1a5a63feaNucala 100 MG InjectionSY24These highlights do not include all the information needed to use NUCALA safely and effectively. See full prescribing information for NUCALA. NUCALA (mepolizumab) for injection, for subcutaneous use NUCALA (mepolizumab) injection, for subcutaneous use Initial U.S. Approval: 201520250806